• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

犬尿喹啉酸在哺乳动物大脑中的存在。

Presence of kynurenic acid in the mammalian brain.

作者信息

Moroni F, Russi P, Lombardi G, Beni M, Carlà V

机构信息

Department of Preclinical and Clinical Pharmacology, University of Florence, Italy.

出版信息

J Neurochem. 1988 Jul;51(1):177-80. doi: 10.1111/j.1471-4159.1988.tb04852.x.

DOI:10.1111/j.1471-4159.1988.tb04852.x
PMID:3379401
Abstract

Kynurenic acid, a tryptophan metabolite able to antagonize the actions of the excitatory amino acids, has been identified and measured for the first time in the brain of mice, rats, guinea pigs, and humans by using an HPLC method. Its content was 5.8 +/- 0.9 in mouse brain, 17.8 +/- 2.0 in rat brain, 16.2 +/- 1.5 in guinea pig brain, 26.8 +/- 2.9 in rabbit brain, and 150 +/- 30 in human cortex (pmol/g wet wt. mean +/- SE). The regional distribution of this molecule was uneven. In rats, guinea pigs, and rabbits, the brainstem was the area richest in this compound. Tryptophan administration (100-300 mg/kg, i.p.) to rats resulted in a significant increase of the brain content of kynurenic acid. Similarly, 1 h after probenecid administration (200 mg/kg, i.p.), the brain content of kynurenate increased by fourfold, thus suggesting that its turnover rate is relatively fast.

摘要

犬尿喹啉酸是一种能够拮抗兴奋性氨基酸作用的色氨酸代谢产物,通过高效液相色谱法首次在小鼠、大鼠、豚鼠和人类的大脑中被鉴定和测量。其含量在小鼠脑中为5.8±0.9,大鼠脑中为17.8±2.0,豚鼠脑中为16.2±1.5,兔脑中为26.8±2.9,人类皮层中为150±30(皮摩尔/克湿重,平均值±标准误)。该分子的区域分布不均匀。在大鼠、豚鼠和兔中,脑干是该化合物含量最丰富的区域。给大鼠腹腔注射色氨酸(100 - 300毫克/千克)会导致犬尿喹啉酸的脑含量显著增加。同样,在给大鼠腹腔注射丙磺舒(200毫克/千克)1小时后,犬尿酸的脑含量增加了四倍,这表明其周转率相对较快。

相似文献

1
Presence of kynurenic acid in the mammalian brain.犬尿喹啉酸在哺乳动物大脑中的存在。
J Neurochem. 1988 Jul;51(1):177-80. doi: 10.1111/j.1471-4159.1988.tb04852.x.
2
Kynurenic acid is present in the rat brain and its content increases during development and aging processes.犬尿喹啉酸存在于大鼠脑中,其含量在发育和衰老过程中会增加。
Neurosci Lett. 1988 Nov 22;94(1-2):145-50. doi: 10.1016/0304-3940(88)90285-6.
3
Identification and measurement of kynurenic acid in the rat brain and other organs.大鼠脑及其他器官中犬尿喹啉酸的鉴定与测定。
Anal Biochem. 1988 Feb 15;169(1):89-94. doi: 10.1016/0003-2697(88)90258-8.
4
Measurement of kynurenic acid in mammalian brain extracts and cerebrospinal fluid by high-performance liquid chromatography with fluorometric and coulometric electrode array detection.采用高效液相色谱法结合荧光和库仑电极阵列检测法测定哺乳动物脑提取物和脑脊液中的犬尿喹啉酸。
Anal Biochem. 1990 Mar;185(2):363-76. doi: 10.1016/0003-2697(90)90309-w.
5
Nicotinylalanine increases the formation of kynurenic acid in the brain and antagonizes convulsions.烟酰基丙氨酸可增加大脑中犬尿喹啉酸的形成并拮抗惊厥。
J Neurochem. 1992 Dec;59(6):2076-80. doi: 10.1111/j.1471-4159.1992.tb10097.x.
6
Experimental diabetes mellitus type 1 increases hippocampal content of kynurenic acid in rats.实验性 1 型糖尿病使大鼠海马内犬尿酸含量增加。
Pharmacol Rep. 2014 Dec;66(6):1134-9. doi: 10.1016/j.pharep.2014.07.014. Epub 2014 Aug 10.
7
Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.通过提高内源性脑犬尿喹啉酸来调节纹状体喹啉酸神经毒性。
Br J Pharmacol. 1998 May;124(2):391-9. doi: 10.1038/sj.bjp.0701834.
8
The effect of peripheral loading with kynurenine and probenecid on extracellular striatal kynurenic acid concentrations.外周给予犬尿氨酸和丙磺舒对纹状体细胞外犬尿喹啉酸浓度的影响。
Neurosci Lett. 1992 Oct 26;146(1):115-8. doi: 10.1016/0304-3940(92)90186-b.
9
Kynurenine and probenecid inhibit pentylenetetrazol- and NMDLA-induced seizures and increase kynurenic acid concentrations in the brain.犬尿氨酸和丙磺舒可抑制戊四氮和N-甲基-D-天冬氨酸诱导的癫痫发作,并增加大脑中犬尿喹啉酸的浓度。
Brain Res Bull. 1992 Feb;28(2):233-8. doi: 10.1016/0361-9230(92)90184-y.
10
Indolpyruvic acid administration increases the brain content of kynurenic acid. Is this a new avenue to modulate excitatory amino acid receptors in vivo?给予吲哚丙酮酸可增加犬尿喹啉酸的脑内含量。这是一条在体内调节兴奋性氨基酸受体的新途径吗?
Biochem Pharmacol. 1989 Aug 1;38(15):2405-9. doi: 10.1016/0006-2952(89)90083-x.

引用本文的文献

1
Importance of Modulating Kynurenic Acid Metabolism-Approaches for the Treatment of Dementia.调节犬尿喹啉酸代谢的重要性——痴呆症的治疗方法
Biomolecules. 2025 Jan 6;15(1):74. doi: 10.3390/biom15010074.
2
Neuroactive Kynurenines as Pharmacological Targets: New Experimental Tools and Exciting Therapeutic Opportunities.神经活性色氨酸代谢产物作为药理学靶点:新的实验工具和令人兴奋的治疗机会。
Pharmacol Rev. 2024 Oct 16;76(6):978-1008. doi: 10.1124/pharmrev.124.000239.
3
The Biology and Biochemistry of Kynurenic Acid, a Potential Nutraceutical with Multiple Biological Effects.
犬尿酸的生物学和生物化学:一种具有多种生物学效应的潜在营养保健品。
Int J Mol Sci. 2024 Aug 21;25(16):9082. doi: 10.3390/ijms25169082.
4
Kynurenine Metabolites in CSF and Plasma in Healthy Males.健康男性脑脊液和血浆中的犬尿氨酸代谢物
Int J Tryptophan Res. 2024 Apr 24;17:11786469241245323. doi: 10.1177/11786469241245323. eCollection 2024.
5
Probenecid, an Old Drug with Potential New Uses for Central Nervous System Disorders and Neuroinflammation.丙磺舒,一种对中枢神经系统疾病和神经炎症可能有新用途的老药。
Biomedicines. 2023 May 24;11(6):1516. doi: 10.3390/biomedicines11061516.
6
Glucocorticoid Hormones as Modulators of the Kynurenine Pathway in Chronic Pain Conditions.糖皮质激素作为慢性疼痛条件下犬尿氨酸途径的调节剂。
Cells. 2023 Apr 18;12(8):1178. doi: 10.3390/cells12081178.
7
Kynurenic acid blunts A1 astrocyte activation against neurodegeneration in HIV-associated neurocognitive disorders.犬尿酸可减弱 HIV 相关神经认知障碍中 A1 星形胶质细胞对神经退行性变的激活作用。
J Neuroinflammation. 2023 Mar 30;20(1):87. doi: 10.1186/s12974-023-02771-4.
8
A Review of the Health Benefits of Food Enriched with Kynurenic Acid.富含犬尿氨酸的食物对健康益处的综述。
Nutrients. 2022 Oct 8;14(19):4182. doi: 10.3390/nu14194182.
9
Influx of kynurenine into the brain is involved in the reduction of ethanol consumption induced by Ro 61-8048 after chronic intermittent ethanol in mice.色氨酸衍生物犬尿氨酸流入大脑与慢性间歇性乙醇处理后罗匹尼罗诱导的小鼠乙醇摄入量减少有关。
Br J Pharmacol. 2022 Jul;179(14):3711-3726. doi: 10.1111/bph.15825. Epub 2022 Mar 7.
10
Galantamine-Memantine Combination and Kynurenine Pathway Enzyme Inhibitors in the Treatment of Neuropsychiatric Disorders.加兰他敏-美金刚联合用药及犬尿氨酸途径酶抑制剂在神经精神疾病治疗中的应用
Complex Psychiatry. 2021 Aug;7(1-2):19-33. doi: 10.1159/000515066. Epub 2021 Feb 8.